Literature DB >> 30672995

Recommendations for hypofractionated whole-breast irradiation.

Nilceana Maya Aires Freitas1, Arthur Accioly Rosa2, Gustavo Nader Marta3,4, Samir Abdalla Hanna4, Rodrigo de Morais Hanriot5, Allisson Bruno Barcelos Borges6, Guilherme Rocha Melo Gondim5,7, Antonio Cassio Assis Pellizzon7, Igor Moreira Veras8, Wilson José de Almeida Júnior9, Claudia Regina Scaramello Hadlich Willis Fernandez10, Eronides Salustiano Batalha Filho11, Marcus Simões Castilho, Felipe Quintino Kuhnen12, Rosa Maria Xavier Faria Najas13, Renato José Affonso Júnior6, André Campana Correia Leite14, Homero Lavieri Martins Ribeiro15, Ruffo Freitas Junior16, Harley Francisco de Oliveira17.   

Abstract

This recommendation consensus for hypofractionated whole-breast radiotherapy (RT) was organized by the Brazilian Society of Radiotherapy (SBRT) considering the optimal scenario for indication and safety in the technology applied. All controversies and contraindication matters (hypofractionated RT in patients who underwent chemotherapy [CT], hypofractionated RT in lymphatic drainage, hypofractionated RT after mastectomy with or without immediate reconstruction, boost during surgery, hypofractionated RT in patients under 50 years old, hypofractionated RT in large breasts, hypofractionated RT in histology of carcinoma in situ [DCIS]) was discussed during a meeting in person, and a consensus was reached when there was an agreement of at least 75% among panel members. The grade for recommendation was also suggested according to the level of scientific evidence available, qualified as weak, medium, or strong. Thus, this consensus will aid Brazilian radiotherapy experts regarding indications and particularities of this technique as a viable and safe alternative for the national reality.

Entities:  

Mesh:

Year:  2018        PMID: 30672995     DOI: 10.1590/1806-9282.64.09.770

Source DB:  PubMed          Journal:  Rev Assoc Med Bras (1992)        ISSN: 0104-4230            Impact factor:   1.209


  6 in total

1.  Hypofractionated radiotherapy in the real-world setting: An international ESTRO-GIRO survey.

Authors:  Danielle Rodin; Bouchra Tawk; Osama Mohamad; Surbhi Grover; Fabio Y Moraes; Mei Ling Yap; Eduardo Zubizarreta; Yolande Lievens
Journal:  Radiother Oncol       Date:  2021-01-14       Impact factor: 6.280

2.  Hypofractionated radiotherapy in breast cancer: a 10-year single institution experience.

Authors:  Gabriel Faria Najas; Silvia Radwanski Stuart; Gustavo Nader Marta; Lorine Arias Bonifácio Teixeira; Vinícius de Carvalho Gico; Alexandre Ruggieri Serante; Geovanne Pedro Mauro; Mateus Costa Lima; Heloisa de Andrade Carvalho
Journal:  Rep Pract Oncol Radiother       Date:  2021-12-30

3.  Moderately hypofractionated post-operative radiation therapy for breast cancer: Systematic review and meta-analysis of randomized clinical trials.

Authors:  Gustavo Nader Marta; Rachel Riera; Rafael Leite Pacheco; Ana Luiza Cabrera Martimbianco; Icro Meattini; Orit Kaidar-Person; Philip Poortmans
Journal:  Breast       Date:  2022-02-03       Impact factor: 4.380

4.  Radiotherapy activity in the COVID 19 pandemic: Brazil's operational national-level study.

Authors:  Fabio Y Moraes; Andre G Gouveia; Renato P Lima; Vanessa F Bratti; Ana C Hamamura; Gustavo A Viani
Journal:  J Cancer Policy       Date:  2022-10-07

5.  Quality and reporting of clinical guidelines for breast cancer treatment: A systematic review.

Authors:  Marta Maes-Carballo; Luciano Mignini; Manuel Martín-Díaz; Aurora Bueno-Cavanillas; Khalid Saeed Khan
Journal:  Breast       Date:  2020-08-10       Impact factor: 4.380

Review 6.  The use of moderately hypofractionated post-operative radiation therapy for breast cancer in clinical practice: A critical review.

Authors:  Gustavo Nader Marta; Charlotte Coles; Orit Kaidar-Person; Icro Meattini; Tarek Hijal; Yvonne Zissiadis; Jean-Philippe Pignol; Duvern Ramiah; Alice Y Ho; Skye Hung-Chun Cheng; Gemma Sancho; Birgitte Vrou Offersen; Philip Poortmans
Journal:  Crit Rev Oncol Hematol       Date:  2020-08-26       Impact factor: 6.312

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.